Status and phase
Conditions
Treatments
About
This study assessed the efficacy and safety of indacaterol (150 µg once daily [od]) when combined with tiotropium (18 µg od) versus tiotropium (18 µg od) treatment alone in patients with chronic obstructive pulmonary disease (COPD).
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Diagnosis of chronic obstructive pulmonary disease (COPD) (moderate-to-severe as classified by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) Guidelines, 2007) and:
Exclusion criteria
Other protocol-defined inclusion/exclusion criteria applied to the study.
Primary purpose
Allocation
Interventional model
Masking
1,142 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal